tiprankstipranks
Trending News
More News >
Hangzhou Tigermed Consulting Co., Ltd. Class H (HK:3347)
:3347

Hangzhou Tigermed Consulting Co., Ltd. Class H (3347) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Hangzhou Tigermed Consulting Co., Ltd. Class H
HK$29.20
€37.83B
69.67
-12.49%
3 Buy
0 Hold
1 Sell
Moderate Buy
Sino Biopharmaceutical
$0.54
$9.55B
39.14
43.78%
2 Buy
1 Hold
0 Sell
Moderate Buy
CSPC Pharmaceutical Group
$0.84
$9.72B
16.45
2.68%
2 Buy
0 Hold
0 Sell
Moderate Buy
Livzon Pharmaceutical Group
$3.56
$4.15B
11.21
2.89%
0 Buy
0 Hold
0 Sell
Moderate Sell
Shanghai Fosun Pharmaceutical (Group) Co
$1.84
$8.07B
12.11
12.50%
0 Buy
0 Hold
0 Sell
Hold
Wuxi Biologics (Cayman)
$2.93
$12.37B
25.79
80.86%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:3347
Hangzhou Tigermed Consulting Co., Ltd. Class H
29.20
-3.33
-10.25%
SBMFF
Sino Biopharmaceutical
0.53
0.17
47.22%
CHJTF
CSPC Pharmaceutical Group
0.84
-0.06
-6.67%
LVZPF
Livzon Pharmaceutical Group
3.56
0.08
2.30%
SFOSF
Shanghai Fosun Pharmaceutical (Group) Co
1.84
0.19
11.52%
WXIBF
Wuxi Biologics (Cayman)
2.93
1.47
100.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis